Key result
Understanding periprocedural management of new antithrombotics is essential to improve patient safety during percutaneous procedures.
Why the study?
Many radiologists are unfamiliar with new antithrombogenic medications and how to modify patient management before nonvascular percutaneous procedures.
Answers are grounded in this paper and cite their sources.
Provides a review of antithrombotic medications and recommendations for their periprocedural management in adults undergoing nonvascular percutaneous procedures in radiology.
OBJECTIVE: Many radiologists are unfamiliar with the new antithrombogenic medications and how to modify patient management before nonvascular percutaneous procedures performed in a radiology department. In this article, we review the indications for use, mechanism of action, pharmacokinetics, dosing, and recommendations for periprocedural management of patients using these medications. CONCLUSION: To improve patient safety, radiologists involved in percutaneous procedures should have knowledge of the antithrombotics that will be encountered routinely in clinical practice.
No takes yet. Share an insight, caveat, or question.
Jaffe et al. (2015) conducted a review in Patients undergoing nonvascular percutaneous procedures. Anticoagulant and antiplatelet medications was evaluated. Understanding the indications, pharmacokinetics, and periprocedural management of new antithrombogenic medications is necessary for radiologists to improve patient safety during percutaneous procedures.
Synapse has enriched 10 related papers. Consider them for comparative context: